Project proposal submitted for the EU Horizon call: Green Pharmaceuticals

A project proposal TransPharm has been submitted on September 21th. For this proposal, the UGent team worked together with our network partners. The scope of the project is the transformation into a sustainable European pharmaceutical sector.

TransPharmA project proposal TransPharm has been submitted on September 21th. For this proposal, the UGent team, under the lead of professor Chris Stevens, worked together with our network partners York and Leuphana. Thanks to this cooperation, the University of Helsinki also joined the network recently. The scope of the project is the transformation into a sustainable European pharmaceutical sector. This project is a cooperation of 11 partners i.e. universities, pharmaceutical industries and governmental institutes.

TransPharm aims to move towards a sustainable pharmaceutical by showing leadership in

- technological innovation and

- the transition to sustainability which is most impactful for the future of this sector.

This is articulated in two tracks that aim to improve the European readiness for sustainable production of small molecules (APIs) that have environmental or supply concerns, i.e.,

(1) Benign-by-Design (Compound level track; directed towards sustainable APIs) and

(2) integrated flow chemistry (Process level track; directed towards sustainable and secured production).

To reach the envisaged aims, the project will deliver four toolboxes for the development of greener pharmaceutical products and APIs, with the aim of

- analysing and predicting flow behaviour and environmental biodegradability of APIs and their synthesis pathways

- identifying greener and more sustainable alternatives to pharmaceutical products / APIs of concern

- reducing the footprint in synthetic schemes of APIs

- assessing the sustainability of pharmaceuticals over their entire life cycle.

These toolboxes will be used to assess the potential to move towards the transition to greener pharmaceutical production.

In addition, we will elaborate on business cases for sustainable pharmaceutical products or APIs and what is needed to bring them to the market. The project will also make sure that key project results and knowledge are properly transferred towards targeted stakeholders.

TransPharm objectives

Let’s hope this project will be approved!